Hellenic Initiative Against Alzheimer’s Disease

Prominent Greek researchers from the Johns Hopkins University, U.S.A., have united their scientific expertise and their research knowledge with scientists from the Bioinformatics and Human Electrophysiology Lab (BiHELab) of the Department of Informatics of the Ionian University, Greece, in order to jointly cope with the progress of Alzheimer’s disease and related dementias in Greece.

This collaboration aims at designing, developing, implementing and following-up a translational research strategic plan for the management of Alzheimer’s disease and related dementias in Greece.

The main objective of the initiative is to put into practice the latest scientific finds in order to face a social threat, which has been recognized as a priority by the World Health Organization. In particular, it has been working on the following:

  • Grow funds for translational research on the Alzheimer’s disease and related dementias (ADRD).
  • Increase competitiveness among Greek scientists in contributing to research.
  • Propose and promote incentives for research in this field.
  • Encourage initiatives regarding therapeutics and medical tourism around ADRD.

The Initiative has been coordinated by: 

Constantine Lyketsos

Director of the Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview, U.S.A., Elizabeth Plank Althouse Professor, Johns Hopkins University, U.S.A., Founding director of the Richman Family Precision Medicine Center of Excellence in Alzheimer’s disease, and Director of the Memory and Alzheimer’s Treatment Center,  Johns Hopkins University, U.S.A.

Panagiotis Vlamos

Professor, Head of Department of Informatics of the Ionian University, Greece, Director of the Bioinformatics and Human Electrophysiology Lab (BiHELab).

Vasiliki Machairaki

Assistant Professor of Genetic Medicine, Medical School of Johns Hopkins University, U.S.A.

Ioannis Tarnanas

Neuroscientist, Senior Fellow for Equity in Brain Health at Global Brain Health Institute (Trinity College Dublin), Founder and Chief Science officer at Altoida.

In the framework of this effort, it is extremely honorary for us both personally and professionally – for our work in thāllo – to participate in this major initiative, as members of the International Advisory Committee, which consists of an interdisciplinary team of prominent Greek and foreign clinicians and researchers.

The initiative is under the auspices of the President of the Hellenic Republic and enjoys the support of the Ministries of Health, Education and Religious Affairs, Tourism, Development and Investments.

For further information visit the official website of the Hellenic Initiative Against Alzheimer’s Disease www.hiaad.org  and the website of thāllo www.thallo.care.

crossmenuchevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram